Central 5-HT3 receptor-induced hypothermia in mice: Interstrain differences and comparison with hypothermia mediated via 5-HT1A receptorNAUMENKO, Vladimir S; KONDAUROVA, Elena M; POPOVA, Nina K et al.Neuroscience letters. 2009, Vol 465, Num 1, pp 50-54, issn 0304-3940, 5 p.Article

Molecular cloning and pharmacological characterization of serotonin 5-HT_3A receptor subtype in dogJENSEN, Thomas N; NIELSEN, Jacob; FREDERIKSEN, Kristen et al.European journal of pharmacology. 2006, Vol 538, Num 1-3, pp 23-31, issn 0014-2999, 9 p.Article

Conception et synthèse d'antagonistes des récepteurs sérotoninergiques 5-HT₃ = Design and synthesis of serotoninergic 5-HT₃ receptor antagonistsRampillon-Garcia, Valérie; Langlois, M.1994, 199 p.Thesis

Ultrastructure of the 5-hydroxytryptamine₃ receptorBOESS, F. G; BEROUKHIM, R; MARTIN, I. L et al.Journal of neurochemistry. 1995, Vol 64, Num 3, pp 1401-1405, issn 0022-3042Article

Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT₃ receptor-mediated von Bezold-Jarisch reflexGODLEWSKI, Grzegorz; GÖTHERT, Manfred; MALINOWSKA, Barbara et al.British journal of pharmacology. 2003, Vol 138, Num 5, pp 767-774, issn 0007-1188, 8 p.Article

The neuronal 5-HT₃ receptor network after 20 years of research - : Evolving concepts in management of pain and inflammationFAERBER, Lothar; DRECHSLER, Sabine; LADENBURGER, Stephan et al.European journal of pharmacology. 2007, Vol 560, Num 1, pp 1-8, issn 0014-2999, 8 p.Article

Effect of pulverization on dehydration behavior of crystals of GK-128, a serotonin₃ receptor antagonistITO, S; KOBAYASHI, Y; NISHIMURA, M et al.Journal of pharmaceutical sciences. 1996, Vol 85, Num 10, pp 1117-1122, issn 0022-3549Article

Immunological characterization and transmembrane topology of 5-hydroxytryptamine₃ receptors by functional epitope taggingMUKERJI, J; HAGHIGHI, A; SEGUELA, P et al.Journal of neurochemistry. 1996, Vol 66, Num 3, pp 1027-1032, issn 0022-3042Article

Stability of ondansetron hydrochloride injection in various beveragesWEERANUJ YAMREUDEEWONG; DANTHI, S. N; HILL, R. A et al.American journal of health-system pharmacy. 1995, Vol 52, Num 18, pp 2011-2014, issn 1079-2082Article

Activation of cholecystokinin (CCK₁) and serotonin (5-HT₃) receptors increases the discharge of pancreatic vagal afferentsMUSSA, Bashair M; SARTOR, Daniela M; VERBEME, Anthony J. M et al.European journal of pharmacology. 2008, Vol 601, Num 1-3, pp 198-206, issn 0014-2999, 9 p.Article

Assignment of a human homolog of the mouse Htr3 receptor gene to chromosome 11q23.1-q23.2WEISS, B; MERTZ, A; SCHRÖCK, E et al.Genomics (San Diego, Calif.). 1995, Vol 29, Num 1, pp 304-305, issn 0888-7543Article

Evidence that the atypical 5-HT₃ receptor ligand, [³H]-BRL46470, labels additional 5-HT₃ binding sites compared to [³H]-granisetronSTEWARD, L. J; JIAN GE; BENTLEY, K. R et al.British journal of pharmacology. 1995, Vol 116, Num 2, pp 1781-1788, issn 0007-1188Article

Synthesis and structural, conformational, biochemical, and pharmacological study of new compounds derived from tropane-3-spiro-4'(5')-imidazoline as potential 5-HT₃ receptor antagonistsWHELAN, B. A; IRIEPA, I; GALVEZ, E et al.Journal of pharmaceutical sciences. 1995, Vol 84, Num 1, pp 101-106, issn 0022-3549Article

5 HT₃-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalitiesQURAISHI, Sadeq A; SCHULER, Gregg H; JANICKI, Piotr K et al.Journal of clinical anesthesia. 2011, Vol 23, Num 4, pp 297-302, issn 0952-8180, 6 p.Article

Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous systemMORALES, M; BATTENBERG, E; DE LECEA, L et al.Molecular brain research. 1996, Vol 36, Num 2, pp 251-260, issn 0169-328XArticle

Itasetron (DAU 6215) prevents age-related memory deficits in the rat in a multiple choice avoidance taskPITSIKAS, N; BORSINI, F.European journal of pharmacology. 1996, Vol 311, Num 2-3, pp 115-119, issn 0014-2999Article

Granisetron : the second serotonin-receptor antagonistADAMS, V. R; VALLEY, A. W.The Annals of pharmacotherapy. 1995, Vol 29, Num 12, pp 1240-1251, issn 1060-0280Article

Repeated dose pharmacokinetics of pancopride in human volunteersSALVA, P; COSTA, J; PEREZ-CAMPOS, A et al.Biopharmaceutics & drug disposition. 1994, Vol 15, Num 8, pp 643-651, issn 0142-2782Article

The role of 5-HT₃-like receptors in the action of clozapineWANG, R. Y; ASHBY, C. R; EDWARDS, E et al.The Journal of clinical psychiatry. 1994, Vol 55, Num SEP, pp 23-26, issn 0160-6689, SUPBConference Paper

5-HT activates vagal afferent cell bodies In Vivo : Role of 5-HT₂ and 5-HT₃ receptorsLACOLLEY, P; OWEN, J. R; SANDOCK, K et al.Neuroscience. 2006, Vol 143, Num 1, pp 273-287, issn 0306-4522, 15 p.Article

In vitro characterization of cytochrome P450 catalysed metabolism of the antiemetic tropisetronFIRKUSNY, L; KROEMER, H. K; EICHELBAUM, M et al.Biochemical pharmacology. 1995, Vol 49, Num 12, pp 1777-1784, issn 0006-2952Article

Prophylaxis of postoperative nausea and vomiting : controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonistsKOVAC, Anthony L.Journal of clinical anesthesia. 2006, Vol 18, Num 4, pp 304-318, issn 0952-8180, 15 p.Article

Reduced 5-HT₃ receptor binding and lower baseline plus maze anxiety in the alcohol-preferring inbred fawn-hooded ratHENSLER, Julie G; HODGE, Clyde W; OVERSTREET, David H et al.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 2, pp 281-289, issn 0091-3057, 9 p.Article

Standard treatment of chemotherapy-induced emesisWARR, D.Supportive care in cancer. 1997, Vol 5, Num 1, pp 12-16, issn 0941-4355Article

Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT₃ receptorsLUMMIS, S. C. R; BAKER, J.Neuropharmacology. 1997, Vol 36, Num 4-5, pp 665-670, issn 0028-3908Article